Oct 31, 2024, 06:01
Nico Gagelmann: Bs Abs as bridging to BCMA CAR-T cell therapy for R/R multiple myeloma
Nico Gagelmann, Co- Chair of the The EBMT Trainee Committee, shared on X:
“Finally out!
Bispecific antibodies as bridging to BCMA CAR-T cell therapy for relapsed/refractory multiple myeloma.”
Authors: David Fandrei, Sabine Seiffert, Michael Rade, Susanne Rieprecht, Nico Gagelmann, Patrick Born, Thomas Wiemers, Heike Weidner, Markus Kreuz, Tamara Schassberger, Jannik Kossmann, Marlene Mangold, Daniel Furst, Luise Fischer, Ronny Baber, Simone Heyn, Song Yau Wang, Enrica Bach, Sandra Hoffmann, Klaus H. Metzeler, Marco Herlling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrike Kohl, Maik Friedrich, Andreas Boldt, Kristin Reiche, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz.
Andreas Boldt
Bispecific antibodies
cancer
Daniel Furst
David Fandrei
Enrica Bach
Georg-Nikolaus Franke
Heike Weidner
Jannik Kossmann
Klaus H Metzeler
Kristin Reiche
Luise Fischer
Madlen Jentzsch
Maik Friedrich
Marco Herlling
Markus Kreuz
Marlene Mangold
Maximilian Merz
Michael Rade
multiple myeloma
Nico Gagelmann
OncoDaily
Oncology
Patrick Born
Ronny Baber
Sabine Seiffert
Sandra Hoffmann
Simone Heyn
Song Yau Wang
Susanne Rieprecht
Tamara Schassberger
Thomas Wiemers
Ulrike Köhl
Uwe Platzbecker
Vladan Vucinic
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 05:59
Dec 22, 2024, 05:31